ABG Analytics logo
 

Eli Lilly & Company (NYSE: LLY)

DRUGS - Drug Manufacturers - Major
Sector: Health Care
Stock price data as of 02/16/2024
Closing price: 782.06
Support price level: $619.84
Resistance price level: N/A
Relative strength index (14-day RSI) 97.2
Beta 0.49
  • LLY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • With a 133.4 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.

  • LLY is one of this month's top performers with a return of 24.4 percent, beating 90 percent of stocks in the S&P-100.

  • Up 5.7 percent, LLY is one of this week's biggest gainers.

  • Volatility is forecast to fall over the next month.

  • With RSI > 70, LLY is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$310.63 $782.06 100.0%
200 day 50 day 20 day 10 day
$546.36 $636.18 $690.73 $738.98
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
30.5% 27.4% 22.4% 26.7%
There is an estimated 5% probability that the stock price of Eli Lilly & Company will fall by more than:
  • 6.1% in the next week.

  • 15.1% in the next month.

  • 54.6% in the next year.